These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12653169)

  • 1. Zafirlukast has no beneficial effects in the treatment of chronic urticaria.
    Reimers A; Pichler C; Helbling A; Pichler WJ; Yawalkar N
    Clin Exp Allergy; 2002 Dec; 32(12):1763-8. PubMed ID: 12653169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results.
    Bagenstose SE; Levin L; Bernstein JA
    J Allergy Clin Immunol; 2004 Jan; 113(1):134-40. PubMed ID: 14713918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid.
    Pacor ML; Di Lorenzo G; Corrocher R
    Clin Exp Allergy; 2001 Oct; 31(10):1607-14. PubMed ID: 11678862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zafirlukast: an update of its pharmacology and therapeutic efficacy in asthma.
    Dunn CJ; Goa KL
    Drugs; 2001; 61(2):285-315. PubMed ID: 11270943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acquired cold urticaria with cetirizine and zafirlukast in combination.
    Bonadonna P; Lombardi C; Senna G; Canonica GW; Passalacqua G
    J Am Acad Dermatol; 2003 Oct; 49(4):714-6. PubMed ID: 14512923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acrivastine versus clemastine in the treatment of chronic idiopathic urticaria. A double-blind, placebo-controlled study.
    Juhlin L; Gibson JR; Harvey SG; Huson LW
    Int J Dermatol; 1987 Dec; 26(10):653-4. PubMed ID: 2892806
    [No Abstract]   [Full Text] [Related]  

  • 7. Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma.
    Adkins JC; Brogden RN
    Drugs; 1998 Jan; 55(1):121-44. PubMed ID: 9463793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of zafirlukast and loratadine on exercise-induced bronchoconstriction.
    Dahlén B; Roquet A; Inman MD; Karlsson O; Naya I; Anstrén G; O'Byrne PM; Dahlén SE
    J Allergy Clin Immunol; 2002 May; 109(5):789-93. PubMed ID: 11994701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria.
    Wan KS
    J Dermatolog Treat; 2009; 20(4):194-7. PubMed ID: 19085267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluticasone propionate compared with zafirlukast in controlling persistent asthma: a randomized double-blind, placebo-controlled trial.
    Busse W; Wolfe J; Storms W; Srebro S; Edwards L; Johnson M; Bowers BW; Rogenes PR; Rickard K
    J Fam Pract; 2001 Jul; 50(7):595-602. PubMed ID: 11485708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukotriene modifiers in chronic urticaria.
    Bensch G; Borish L
    Ann Allergy Asthma Immunol; 1999 Oct; 83(4):348. PubMed ID: 10541429
    [No Abstract]   [Full Text] [Related]  

  • 12. Zafirlukast: the first leukotriene-receptor antagonist approved for the treatment of asthma.
    Kelloway JS
    Ann Pharmacother; 1997 Sep; 31(9):1012-21. PubMed ID: 9296243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids.
    Virchow JC; Prasse A; Naya I; Summerton L; Harris A
    Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):578-85. PubMed ID: 10934090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of montelukast as added therapy in patients with chronic idiopathic urticaria.
    Khan S; Lynch N
    Inflamm Allergy Drug Targets; 2012 Jun; 11(3):235-43. PubMed ID: 22452602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
    Cazzola M; Centanni S; Boveri B; Di Marco F; Santus P; Matera MG; Allegra L
    Respiration; 2001; 68(5):452-9. PubMed ID: 11694805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.
    Suissa S; Dennis R; Ernst P; Sheehy O; Wood-Dauphinee S
    Ann Intern Med; 1997 Feb; 126(3):177-83. PubMed ID: 9027267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nasal budesonide plus zafirlukast vs nasal budesonide plus loratadine-pseudoephedrine for controlling the symptoms of rhinitis and asthma].
    Benitez HH; Arvizu VM; Gutiérrez DJ; Fogelbach GA; Castellanos Olivares A; Vázquez Nava F; Velázquez HC; González Pérez Mdel C; Mora Nieto A; Rodríguez EC
    Rev Alerg Mex; 2005; 52(2):90-5. PubMed ID: 16158782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of acrivastine versus terfenadine and placebo in the treatment of chronic idiopathic urticaria.
    van Joost T; Blog FB; Westerhof W; Jansen FC; Starink TM; den Boer MS; Kuneman JJ; Harvey SG; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():14B-17B. PubMed ID: 2569995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of acrivastine versus hydroxyzine and placebo in the treatment of chronic idiopathic urticaria.
    Salo OP; Harvey SG; Calthrop JG; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():18B-21B. PubMed ID: 2569996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the leukotriene receptor antagonist zafirlukast on neurokinin A-induced bronchoconstriction in patients with asthma--A comparison with leukotriene D4 induced broncoconstriction.
    Schelfhout V; Van De Velde V; Pauwels R; Joos G
    Pulm Pharmacol Ther; 2008; 21(2):276-84. PubMed ID: 17611132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.